Clinical Trial Update: Methotrexate (Rheumatrex) High Dose Special Investigation (Regulatory Post Marketing Commitment Plan)

View source ↗

Summary

A completed clinical trial update on high-dose methotrexate (Rheumatrex) under a regulatory post-marketing commitment plan for arthritis/rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arthritis
• Rheumatoid Arthritis

Drugs mentioned

• Rheumatrex (methotrexate)

Snippet

Sponsor: Pfizer | Conditions: Arthritis, Rheumatoid | Status: COMPLETED | Results posted: 2018-08-06